Cargando…
Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment
COPD is a typical example of chronic disease. As such, treatment adherence tends to be as low as between 30% and 50%, with specific issues in COPD due to the use of inhaled therapies. Decreased adherence in COPD is associated with worse outcomes, with increased risk for exacerbations and long-term m...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697822/ http://dx.doi.org/10.2147/COPD.S431829 |
_version_ | 1785154815668518912 |
---|---|
author | Turégano-Yedro, Miguel Trillo-Calvo, Eva Navarro i Ros, Fernando Maya-Viejo, José David González Villaescusa, Cruz Echave Sustaeta, Jose Maria Doña, Esperanza Alcázar Navarrete, Bernardino |
author_facet | Turégano-Yedro, Miguel Trillo-Calvo, Eva Navarro i Ros, Fernando Maya-Viejo, José David González Villaescusa, Cruz Echave Sustaeta, Jose Maria Doña, Esperanza Alcázar Navarrete, Bernardino |
author_sort | Turégano-Yedro, Miguel |
collection | PubMed |
description | COPD is a typical example of chronic disease. As such, treatment adherence tends to be as low as between 30% and 50%, with specific issues in COPD due to the use of inhaled therapies. Decreased adherence in COPD is associated with worse outcomes, with increased risk for exacerbations and long-term mortality. Factors that impact adherence are multiple, some related to patient, some related to clinicians and finally some related to healthcare system. Among clinician factors, prescription of simplified treatment regimens delivered by an inhaler adapted to the patient’s characteristics is crucial. Although it has been observed a huge improvement in the design and usability of inhaler devices for COPD in the last two centuries, there is still a clear gap in this field. Smart inhalers as well as simplified treatment regimens could improve adherence and therefore improve long-term outcomes in COPD. |
format | Online Article Text |
id | pubmed-10697822 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-106978222023-12-06 Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment Turégano-Yedro, Miguel Trillo-Calvo, Eva Navarro i Ros, Fernando Maya-Viejo, José David González Villaescusa, Cruz Echave Sustaeta, Jose Maria Doña, Esperanza Alcázar Navarrete, Bernardino Int J Chron Obstruct Pulmon Dis Review COPD is a typical example of chronic disease. As such, treatment adherence tends to be as low as between 30% and 50%, with specific issues in COPD due to the use of inhaled therapies. Decreased adherence in COPD is associated with worse outcomes, with increased risk for exacerbations and long-term mortality. Factors that impact adherence are multiple, some related to patient, some related to clinicians and finally some related to healthcare system. Among clinician factors, prescription of simplified treatment regimens delivered by an inhaler adapted to the patient’s characteristics is crucial. Although it has been observed a huge improvement in the design and usability of inhaler devices for COPD in the last two centuries, there is still a clear gap in this field. Smart inhalers as well as simplified treatment regimens could improve adherence and therefore improve long-term outcomes in COPD. Dove 2023-12-04 /pmc/articles/PMC10697822/ http://dx.doi.org/10.2147/COPD.S431829 Text en © 2023 Turégano-Yedro et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Turégano-Yedro, Miguel Trillo-Calvo, Eva Navarro i Ros, Fernando Maya-Viejo, José David González Villaescusa, Cruz Echave Sustaeta, Jose Maria Doña, Esperanza Alcázar Navarrete, Bernardino Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment |
title | Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment |
title_full | Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment |
title_fullStr | Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment |
title_full_unstemmed | Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment |
title_short | Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment |
title_sort | inhaler adherence in copd: a crucial step towards the correct treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697822/ http://dx.doi.org/10.2147/COPD.S431829 |
work_keys_str_mv | AT tureganoyedromiguel inhaleradherenceincopdacrucialsteptowardsthecorrecttreatment AT trillocalvoeva inhaleradherenceincopdacrucialsteptowardsthecorrecttreatment AT navarroirosfernando inhaleradherenceincopdacrucialsteptowardsthecorrecttreatment AT mayaviejojosedavid inhaleradherenceincopdacrucialsteptowardsthecorrecttreatment AT gonzalezvillaescusacruz inhaleradherenceincopdacrucialsteptowardsthecorrecttreatment AT echavesustaetajosemaria inhaleradherenceincopdacrucialsteptowardsthecorrecttreatment AT donaesperanza inhaleradherenceincopdacrucialsteptowardsthecorrecttreatment AT alcazarnavarretebernardino inhaleradherenceincopdacrucialsteptowardsthecorrecttreatment |